Blar i NTNU Open på forfatter "Scott-Wilson, C"
-
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
Lotvall, J; Bakke, Per S.; Bjermer, Leif; Steinshamn, Sigurd Loe; Scott-Wilson, C; Crim, Courtney; Sanford, L; Haumann, B (Journal article; Peer reviewed, 2012)Background: Fluticasone furoate/vilanterol (FF/VI) is a novel once-daily (OD) inhaled corticosteroid/long-acting β2 agonist combination in development for chronic obstructive pulmonary disease (COPD) and asthma. Trial ...